Aspen eyes Serum Institute model as it seeks licence to make J&J vaccine – Reuters

An Aspen Pharmacare logo is seen at outside company offices in Woodmead, Johannesburg, South Africa, September 13, 2018. REUTERS/Siphiwe Sibeko
JOHANNESBURG, Sept 2 (Reuters) – South Africa's Aspen Pharmacare (APNJ.J) wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson & Johnson's (J&J) (JNJ.N) COVID-19 vaccine, Aspen Chief Executive Stephen Saad said on Thursday.
"At the moment, J&J could take all the product we make because it's their product, and sell it to Europe, for example, sell it to the U.S. or Korea, wherever they choose to. We have no say in that," he told Reuters.
"It's like Serum where they get the licences to manufacture. It's not a foreign model and it's very exciting," he said on the licensing talks.
Our Standards: The Thomson Reuters Trust Principles.
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
A Texas abortion ban that is the strictest in the United States in almost half a century will remain in place for the foreseeable future after a U.S. Supreme Court decision that raised questions about how it will rule on another upcoming case on women's rights.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Information, analytics and exclusive news on financial markets – delivered in an intuitive desktop and mobile interface.
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved


Leave a Reply

Your email address will not be published. Required fields are marked *